Artigos com autorizações de acesso público - Nik Caldas ramirezSaiba mais
Não disponíveis em nenhum local: 18
Rever
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ...
The lancet oncology 15 (4), 406-414, 2014
Autorizações: Cancer Research UK, UK Medical Research Council, National Institute for …
Rever
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
J Stingl, C Caldas
Nature Reviews Cancer 7 (10), 791-799, 2007
Autorizações: Cancer Research UK
Rever
Triple negative breast cancers: clinical and prognostic implications
SJ Dawson, E Provenzano, C Caldas
European journal of cancer 45, 27-40, 2009
Autorizações: British Heart Foundation
Rever
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
B Li, T Ni Chonghaile, Y Fan, SF Madden, R Klinger, AE O'Connor, ...
Cancer research 77 (14), 3834-3845, 2017
Autorizações: Science Foundation Ireland, Cancer Research UK, UK Medical Research Council …
Rever
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer
HR Ali, SJ Dawson, FM Blows, E Provenzano, S Leung, T Nielsen, ...
The Journal of pathology 226 (1), 97-107, 2012
Autorizações: Cancer Research UK
Rever
Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer
M Frye, I Dragoni, SF Chin, I Spiteri, A Kurowski, E Provenzano, A Green, ...
Cancer letters 289 (1), 71-80, 2010
Autorizações: Cancer Research UK
Rever
Genetic predisposition to gastro-oesophageal cancer
P Lao-Sirieix, C Caldas, RC Fitzgerald
Current opinion in genetics & development 20 (3), 210-217, 2010
Autorizações: Cancer Research UK
Rever
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
N Ben-Chetrit, D Chetrit, R Russell, C Koerner, M Mancini, A Abdul-Hai, ...
Science Signaling 8 (360), ra7-ra7, 2015
Autorizações: US National Institutes of Health, Cancer Research UK, National Institute for …
Rever
Clinical utility of whole-genome sequencing in precision oncology
R Rosenquist, E Cuppen, R Buettner, C Caldas, H Dreau, O Elemento, ...
Seminars in Cancer Biology 84, 32-39, 2022
Autorizações: Knut and Alice Wallenberg Foundation, Swedish Research Council, Cancer …
Rever
Cancer treatment in the genomic era
GJ Doherty, M Petruzzelli, E Beddowes, SS Ahmad, C Caldas, ...
Annual review of biochemistry 88 (1), 247-280, 2019
Autorizações: Cancer Research UK, UK Medical Research Council
Rever
Nucleosome mapping in plasma DNA predicts cancer gene expression
M Murtaza, C Caldas
Nature Genetics 48 (10), 1105-1106, 2016
Autorizações: Cancer Research UK, National Institute for Health Research, UK
Rever
Predicting treatment resistance and relapse through circulating DNA
E Beddowes, SJ Sammut, M Gao, C Caldas
The Breast 34, S31-S35, 2017
Autorizações: Cancer Research UK, UK Medical Research Council
Rever
BET inhibition as a rational therapeutic strategy for invasive lobular breast cancer
L Walsh, KE Haley, B Moran, B Mooney, F Tarrant, SF Madden, ...
Clinical Cancer Research 25 (23), 7139-7150, 2019
Autorizações: Science Foundation Ireland, Breast Cancer Now, UK, Cancer Research UK …
Rever
Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology
V Jobanputra, KO Wrzeszczynski, R Buttner, C Caldas, E Cuppen, ...
Seminars in Cancer Biology 84, 23-31, 2022
Autorizações: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Rever
Finding common regions of alteration in copy number data
OM Rueda, R Diaz-Uriarte, C Caldas
Array Comparative Genomic Hybridization: Protocols and Applications, 339-353, 2013
Autorizações: Cancer Research UK, Government of Spain
Rever
Cameron C. Young, Katherine Eason, Raquel Manzano Garcia, Richard Moulange 3
S Mukherjee, SF Chin, C Caldas, OM Rueda
Scientific Reports 14, 11861, 2024
Autorizações: Cancer Research UK, UK Medical Research Council, National Institute for …
Rever
Bcl11a Marks Mammary Progenitor Cells and Promotes Early Cellular Changes Associated with TNBC by Recruiting Chd8
S Pensa, KA Lazarus, K Bach, MF Santolla, M Maggiolini, J Cassidy, ...
Available at SSRN 3224558, 2018
Autorizações: Cancer Research UK
Rever
High expression of Rsf-1 correlates with poor prognosis in breast cancer
S Hamarsheh, C Joseph, M Craze, E Provenzano, C Nolan, C Caldas, ...
European Journal of Surgical Oncology 42 (11), S251, 2016
Autorizações: National Institute for Health Research, UK
Disponíveis em algum local: 367
Rever
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
nature 500 (7463), 415-421, 2013
Autorizações: US National Institutes of Health, Wellcome Trust
Rever
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
Autorizações: US National Institutes of Health, Cancer Research UK
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.